Innovations that are Eternal in Nature
- Innovations that are Eternal in nature
- Faster Drug Development Process
- Reduced Risk of Failure
about us
Beside - to - Bench Approach
Our organization strives to carry out intensive scientific studies on time tested and highly efficacious clinical remedies to translate them into leads that can be further developed into potential drug candidates that are effective and safe.
We have adopted “Bedside-to-bench” approach wherein the knowledge gained from the successful clinical experience is evaluated into developing drugs that have multimodal actions, good safety profile and promising disease segmentation.
It is hypothesized that the drugs work on numerous, complex and interrelated pathways that need to be explored with multidisciplinary approach to understand the exact mechanism of action of these drugs.
We are conducting exploratory clinical studies in humans along with preclinical studies to strengthen the disease segmentation of the drugs and generate proof of concept to support the commercialization efforts. Efficacy glimpses in the clinical setting provide strong conviction in the development of these molecules.
Significant advantage of such approach is faster drug development process and reduced risk of failure. Moreover, this approach has a potential of developing “Innovations that are Eternal in nature”
We have adopted “Bedside-to-bench” approach wherein the knowledge gained from the successful clinical experience is evaluated into developing drugs that have multimodal actions, good safety profile and promising disease segmentation.
It is hypothesized that the drugs work on numerous, complex and interrelated pathways that need to be explored with multidisciplinary approach to understand the exact mechanism of action of these drugs.
We are conducting exploratory clinical studies in humans along with preclinical studies to strengthen the disease segmentation of the drugs and generate proof of concept to support the commercialization efforts. Efficacy glimpses in the clinical setting provide strong conviction in the development of these molecules.
Significant advantage of such approach is faster drug development process and reduced risk of failure. Moreover, this approach has a potential of developing “Innovations that are Eternal in nature”
“Conventional Approach” Vs “RBPL’s Approach”
